AN ACT CONCERNING THE ROLE OF CLINICAL PEERS IN ADVERSE DETERMINATION AND UTILIZATION REVIEWS.
To: (1) Redefine "clinical peer" for the purposes of adverse determination and utilization reviews; and (2) require health carriers to provide certain clinical peers with the authority to reverse initial adverse determinations.
Introduced by:Insurance and Real Estate Committee
|New today||2-4 days old||5 days & older|
Add Notes to SB-335
Co-sponsors for Amendment LCO:
|3/2/2020||Public Hearing 03/05|
|2/27/2020||Referred to Joint Committee on Insurance and Real Estate|